Efficacy of entecavir versus tenofovir disoproxil fumarate in preventing hepatocellular carcinoma-The jury is out

被引:0
|
作者
Peng, Cheng-Yuan [1 ,2 ,3 ]
机构
[1] China Med Univ Hosp, Ctr Digest Med, Dept Internal Med, Taichung, Taiwan
[2] China Med Univ, Sch Med, Taichung, Taiwan
[3] China Med Univ Hosp, Ctr Digest Med, Dept Internal Med, 2 Yude Rd, Taichung 404332, Taiwan
关键词
CHRONIC HEPATITIS-B; RISK;
D O I
10.1002/aid2.13391
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:5 / 7
页数:3
相关论文
共 50 条
  • [41] The Use of Tenofovir Disoproxil Fumarate and Tenofovir Alafenamide for Preventing Vertical Transmission of Hepatitis B
    Zhu, Lin
    Park, Jaimie
    Deng, You Q.
    Pan, Calvin Q.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2023, 57 (02) : 127 - 138
  • [42] Cost-effectiveness of switching from tenofovir disoproxil fumarate to tenofovir alafenamide versus entecavir for chronic hepatitis B patients in Greece
    Sinakos, Emmanouil
    Kachru, Nandita
    Tsoulas, Christos
    Jeyakumar, Sushanth
    Smith, Nathaniel J.
    Yehoshua, Alon
    Cholongitas, Evangelos
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2024, 13 (04) : e230090
  • [43] To use entecavir, tenofovir disoproxil fumarate or tenofovir alafenamide: it's all about choosing the right patient!
    Satsangi, Sandeep
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2018, 30 (06) : 689 - 690
  • [44] COMPARATIVE EFFICACY AND RENAL SAFETY OF ENTECAVIR, TENOFOVIR DISOPROXIL FUMARATE AND TENOFOVIR ALAFENAMIDE FOR HBV-INFECTED CANCER PATIENTS UNDERGOING CHEMOTHERAPY
    Lee, I-Cheng
    Lan, Keng-Hsin
    Su, Chien-Wei
    Chao, Yee
    Lin, Han-Chieh
    Hou, Ming-Chih
    Huang, Yi Hsiang
    HEPATOLOGY, 2021, 74 : 473A - 474A
  • [45] Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in treatment-naive chronic hepatitis B
    Lim, Jihye
    Choi, Won-Mook
    Shim, Ju Hyun
    Lee, Danbi
    Kim, Kang Mo
    Lim, Young-Suk
    Lee, Han Chu
    Choi, Jonggi
    LIVER INTERNATIONAL, 2022, 42 (07) : 1517 - 1527
  • [46] The role of tenofovir disoproxil fumarate for preventing vertical transmission of hepatitis B
    Pan, Calvin Q.
    ANTIVIRAL THERAPY, 2022, 27 (02)
  • [47] Atherosclerotic CVD risk profile of tenofovir alafenamide versus tenofovir disoproxil fumarate
    Huhn, G.
    Shamblaw, D.
    Baril, J. G.
    Baker, D.
    Ward, D.
    Guo, S.
    Haubrich, R.
    Nguyen-Cleary, T.
    McCallister, S.
    Das, M.
    ANTIVIRAL THERAPY, 2016, 21 : A45 - A45
  • [48] Comparative Meta-Analysis of Tenofovir Disoproxil Fumarate versus Emtricitabine and Tenofovir Disoproxil Fumarate as Treatments for Patients with Chronic Hepatitis B
    Cui, Guangying
    Xu, Xuejun
    Diao, Hongyan
    SCIENTIFIC REPORTS, 2015, 5
  • [49] ENTECAVIR VERSUS TENOFOVIR DISOPROXIL FUMARATE FOR SEROCLEARANCE OF HEPATITIS B SURFACE ANTIGEN IN AN INTERNATIONAL REAL-WORLD COHORT
    Hsu, Yao-Chun
    Jun, Dae Won
    Peng, Cheng-Yuan
    Yeh, Ming-Lun
    Trinh, Huy N.
    Wong, Grace L. H.
    Kim, Sung Eun
    Chen, Chien Hung
    Oh, Hyunwoo
    Lin, Chia-Hsin
    Yoon, Eileen
    Ahn, Sang Bong
    Huang, Daniel
    Cho, Yong Kyun
    Jeong, Jae Yoon
    Jeong, Soung Won
    Kim, Hyoung Su
    Xie, Qing
    Liu, Li
    Riveiro Barciela, Mar
    Tsai, Pei-Chien
    Vargas-Accarino, Elena
    Toyoda, Hidenori
    Enomoto, Masaru
    Preda, Carmen
    Marciano, Sebastian
    Hoang, Joseph
    Huang, Chung-Feng
    Kozuka, Ritsuzo
    Yasuda, Satoshi
    Istratescu, Doina
    Lee, Dong Hyun
    Su, Jia-Ying
    Huang, Yen-Tsung
    Huang, Jee-Fu
    Dai, Chia-Yen
    Chuang, Wan-Long
    Yuen, Man-Fung
    Gadano, Adrian C.
    Cheung, Ramsey C.
    Lim, Seng Gee
    Buti, Maria
    Wong, Vincent Wai-Sun
    Yu, Ming-Lung
    Nguyen, Mindie H.
    HEPATOLOGY, 2021, 74 : 434A - 436A
  • [50] Comparative Meta-Analysis of Tenofovir Disoproxil Fumarate versus Emtricitabine and Tenofovir Disoproxil Fumarate as Treatments for Patients with Chronic Hepatitis B
    Guangying Cui
    Xuejun Xu
    Hongyan Diao
    Scientific Reports, 5